Iloperidone 1 MG Oral Tablet — RxCUI 848722
RxNorm drug concept · Semantic clinical drug
RxCUI 848722
Semantic clinical drug · SCD
● Current RxNorm concept 24 FDA products
38 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI848722
Official nameIloperidone 1 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped24
Package NDCs mapped38
Reported Medicaid activity (SDUD)31,677 prescriptions · 38 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Iloperidone: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Iloperidone tablets are approved to treat schizophrenia in adults. If you've been prescribed the brand Fanapt, it has one additional approved use: treating acute manic or mixed epi...
- Iloperidone can cause a significant drop in blood pressure when you first start it — especially when you stand up quickly — which can make you dizzy or even faint. That's called or...
- Why do I have to start on such a small dose and increase it slowly?
- The most common side effects include dizziness (especially when standing), drowsiness, dry mouth, a fast heartbeat, nasal congestion, fatigue, and some weight gain. Most of these e...
🕸️ Concept Web — How Iloperidone 1 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Iloperidone 1 MG Oral Tablet
RxCUI 848722 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Iloperidone
73178IN
-
Iloperidone
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Fanapt
848723BN
-
Fanapt
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Iloperidone Oral Tablet
848721SCDF -
Iloperidone Oral Product
1160677SCDG -
Iloperidone Pill
1160678SCDG -
Iloperidone Oral Tablet [Fanapt]
848725SBDF -
Fanapt Oral Product
1174678SBDG -
Fanapt Pill
1174679SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Iloperidone Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Iloperidone 1 MG
848720SCDC -
Iloperidone 1 MG Oral Tablet [Fanapt]
848726SBD -
Iloperidone 1 MG [Fanapt]
848724SBDC
-
Iloperidone 1 MG
-
Packs 6
Fixed collections of drugs packaged and sold together, like dose packs.
-
{2 (iloperidone 1 MG Oral Tablet [Fanapt]) / 2 (iloperidone 2 MG Oral Tablet [Fanapt]) / 2 (iloperidone 4 MG Oral Tablet [Fanapt]) / 2 (iloperidone 6 MG Oral Tablet [Fanapt]) } Pack [Fanapt Titration Pack]
848752BPCK -
{4 (iloperidone 1 MG Oral Tablet [Fanapt]) / 2 (iloperidone 2 MG Oral Tablet [Fanapt]) / 2 (iloperidone 6 MG Oral Tablet [Fanapt]) } Pack [Fanapt Titration Pack C]
2714235BPCK -
{6 (iloperidone 1 MG Oral Tablet [Fanapt]) / 2 (iloperidone 2 MG Oral Tablet [Fanapt]) / 2 (iloperidone 6 MG Oral Tablet [Fanapt]) / 2 (iloperidone 8 MG Oral Tablet [Fanapt]) } Pack [Fanapt Titration Pack B]
2720357BPCK -
{2 (iloperidone 1 MG Oral Tablet) / 2 (iloperidone 2 MG Oral Tablet) / 2 (iloperidone 4 MG Oral Tablet) / 2 (iloperidone 6 MG Oral Tablet) } Pack
848751GPCK -
{4 (iloperidone 1 MG Oral Tablet) / 2 (iloperidone 2 MG Oral Tablet) / 2 (iloperidone 6 MG Oral Tablet) } Pack
2714234GPCK -
{6 (iloperidone 1 MG Oral Tablet) / 2 (iloperidone 2 MG Oral Tablet) / 2 (iloperidone 6 MG Oral Tablet) / 2 (iloperidone 8 MG Oral Tablet) } Pack
2720356GPCK
-
{2 (iloperidone 1 MG Oral Tablet [Fanapt]) / 2 (iloperidone 2 MG Oral Tablet [Fanapt]) / 2 (iloperidone 4 MG Oral Tablet [Fanapt]) / 2 (iloperidone 6 MG Oral Tablet [Fanapt]) } Pack [Fanapt Titration Pack]
Showing up to 8 concepts per family — 19 of 20 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
{2 (iloperidone 1 MG Oral Tablet) / 2 (iloperidone 2 MG Oral Tablet) / 2 (iloperidone 4 MG Oral Tablet) / 2 (iloperidone 6 MG Oral Tablet) } Pack
GPCK · 848751 -
{4 (iloperidone 1 MG Oral Tablet) / 2 (iloperidone 2 MG Oral Tablet) / 2 (iloperidone 6 MG Oral Tablet) } Pack
GPCK · 2714234 -
{6 (iloperidone 1 MG Oral Tablet) / 2 (iloperidone 2 MG Oral Tablet) / 2 (iloperidone 6 MG Oral Tablet) / 2 (iloperidone 8 MG Oral Tablet) } Pack
GPCK · 2720356 -
Iloperidone 1 MG
SCDC · 848720 -
Iloperidone Oral Tablet
SCDF · 848721 -
Iloperidone Oral Product
SCDG · 1160677 -
Iloperidone Pill
SCDG · 1160678
Brand-Name Concepts
-
Iloperidone 1 MG Oral Tablet [Fanapt]
SBD · 848726 -
{2 (iloperidone 1 MG Oral Tablet [Fanapt]) / 2 (iloperidone 2 MG Oral Tablet [Fanapt]) / 2 (iloperidone 4 MG Oral Tablet [Fanapt]) / 2 (iloperidone 6 MG Oral Tablet [Fanapt]) } Pack [Fanapt Titration Pack]
BPCK · 848752 -
{4 (iloperidone 1 MG Oral Tablet [Fanapt]) / 2 (iloperidone 2 MG Oral Tablet [Fanapt]) / 2 (iloperidone 6 MG Oral Tablet [Fanapt]) } Pack [Fanapt Titration Pack C]
BPCK · 2714235 -
{6 (iloperidone 1 MG Oral Tablet [Fanapt]) / 2 (iloperidone 2 MG Oral Tablet [Fanapt]) / 2 (iloperidone 6 MG Oral Tablet [Fanapt]) / 2 (iloperidone 8 MG Oral Tablet [Fanapt]) } Pack [Fanapt Titration Pack B]
BPCK · 2720357 -
Iloperidone 1 MG [Fanapt]
SBDC · 848724 -
Iloperidone Oral Tablet [Fanapt]
SBDF · 848725 -
Fanapt Oral Product
SBDG · 1174678 -
Fanapt Pill
SBDG · 1174679 -
Fanapt
BN · 848723
📦 FDA Products & Package NDCs
24 products · 38 package NDCs
38 package NDCs map to RxCUI 848722 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00378-0630-01 | 100 TABLET in 1 BOTTLE (0378-0630-01) | ILOPERIDONE | Mylan Pharmaceuticals Inc. | 2017-03-20 |
| 00378-0630-88 | 10 BLISTER PACK in 1 CARTON (0378-0630-88) / 10 TABLET in 1... | ILOPERIDONE | Mylan Pharmaceuticals Inc. | 2017-03-20 |
| 00378-0630-91 | 60 TABLET in 1 BOTTLE (0378-0630-91) | ILOPERIDONE | Mylan Pharmaceuticals Inc. | 2017-03-20 |
| 00378-0631-01 | 100 TABLET in 1 BOTTLE (0378-0631-01) | ILOPERIDONE | Mylan Pharmaceuticals Inc. | 2017-03-20 |
| 00378-0631-88 | 10 BLISTER PACK in 1 CARTON (0378-0631-88) / 10 TABLET in 1... | ILOPERIDONE | Mylan Pharmaceuticals Inc. | 2017-03-20 |
| 00378-0631-91 | 60 TABLET in 1 BOTTLE (0378-0631-91) | ILOPERIDONE | Mylan Pharmaceuticals Inc. | 2017-03-20 |
| 00378-0632-01 | 100 TABLET in 1 BOTTLE (0378-0632-01) | ILOPERIDONE | Mylan Pharmaceuticals Inc. | 2017-03-20 |
| 00378-0632-88 | 10 BLISTER PACK in 1 CARTON (0378-0632-88) / 10 TABLET in 1... | ILOPERIDONE | Mylan Pharmaceuticals Inc. | 2017-03-20 |
| 00378-0632-91 | 60 TABLET in 1 BOTTLE (0378-0632-91) | ILOPERIDONE | Mylan Pharmaceuticals Inc. | 2017-03-20 |
| 00378-0633-01 | 100 TABLET in 1 BOTTLE (0378-0633-01) | ILOPERIDONE | Mylan Pharmaceuticals Inc. | 2017-03-20 |
| 00378-0633-88 | 10 BLISTER PACK in 1 CARTON (0378-0633-88) / 10 TABLET in 1... | ILOPERIDONE | Mylan Pharmaceuticals Inc. | 2017-03-20 |
| 00378-0633-91 | 60 TABLET in 1 BOTTLE (0378-0633-91) | ILOPERIDONE | Mylan Pharmaceuticals Inc. | 2017-03-20 |
| 00378-0634-01 | 100 TABLET in 1 BOTTLE (0378-0634-01) | ILOPERIDONE | Mylan Pharmaceuticals Inc. | 2017-03-20 |
| 00378-0634-88 | 10 BLISTER PACK in 1 CARTON (0378-0634-88) / 10 TABLET in 1... | ILOPERIDONE | Mylan Pharmaceuticals Inc. | 2017-03-20 |
| 00378-0634-91 | 60 TABLET in 1 BOTTLE (0378-0634-91) | ILOPERIDONE | Mylan Pharmaceuticals Inc. | 2017-03-20 |
| 00378-0635-01 | 100 TABLET in 1 BOTTLE (0378-0635-01) | ILOPERIDONE | Mylan Pharmaceuticals Inc. | 2017-03-20 |
| 00378-0635-88 | 10 BLISTER PACK in 1 CARTON (0378-0635-88) / 10 TABLET in 1... | ILOPERIDONE | Mylan Pharmaceuticals Inc. | 2017-03-20 |
| 00378-0635-91 | 60 TABLET in 1 BOTTLE (0378-0635-91) | ILOPERIDONE | Mylan Pharmaceuticals Inc. | 2017-03-20 |
| 00378-0636-01 | 100 TABLET in 1 BOTTLE (0378-0636-01) | ILOPERIDONE | Mylan Pharmaceuticals Inc. | 2017-03-20 |
| 00378-0636-88 | 10 BLISTER PACK in 1 CARTON (0378-0636-88) / 10 TABLET in 1... | ILOPERIDONE | Mylan Pharmaceuticals Inc. | 2017-03-20 |
| 00378-0636-91 | 60 TABLET in 1 BOTTLE (0378-0636-91) | ILOPERIDONE | Mylan Pharmaceuticals Inc. | 2017-03-20 |
| 43068-0101-02 | 60 TABLET in 1 BOTTLE (43068-101-02) | FANAPT | Vanda Pharmaceuticals Inc. | 2016-05-01 |
| 43068-0102-02 | 60 TABLET in 1 BOTTLE (43068-102-02) | FANAPT | Vanda Pharmaceuticals Inc. | 2016-08-01 |
| 43068-0104-02 | 60 TABLET in 1 BOTTLE (43068-104-02) | FANAPT | Vanda Pharmaceuticals Inc. | 2015-12-15 |
| 43068-0106-02 | 60 TABLET in 1 BOTTLE (43068-106-02) | FANAPT | Vanda Pharmaceuticals Inc. | 2016-07-01 |
| 43068-0108-02 | 60 TABLET in 1 BOTTLE (43068-108-02) | FANAPT | Vanda Pharmaceuticals Inc. | 2015-09-15 |
| 43068-0110-02 | 60 TABLET in 1 BOTTLE (43068-110-02) | FANAPT | Vanda Pharmaceuticals Inc. | 2016-01-15 |
| 43068-0112-02 | 60 TABLET in 1 BOTTLE (43068-112-02) | FANAPT | Vanda Pharmaceuticals Inc. | 2016-10-15 |
| 43068-0113-04 | 1 BLISTER PACK in 1 DOSE PACK (43068-113-04) / 1 KIT in 1 B... | FANAPT | Vanda Pharmaceuticals Inc. | 2015-12-01 |
| 43068-0114-03 | 1 BLISTER PACK in 1 DOSE PACK (43068-114-03) / 1 KIT in 1 B... | FANAPT | Vanda Pharmaceuticals Inc. | 2025-05-01 |
| 43068-0115-04 | 1 BLISTER PACK in 1 DOSE PACK (43068-115-04) / 1 KIT in 1 B... | FANAPT | Vanda Pharmaceuticals Inc. | 2025-08-01 |
| 43068-0901-14 | 14 TABLET in 1 BOTTLE (43068-901-14) | FANAPT | Vanda Pharmaceuticals Inc. | 2018-09-24 |
| 43068-0902-14 | 14 TABLET in 1 BOTTLE (43068-902-14) | FANAPT | Vanda Pharmaceuticals Inc. | 2018-09-24 |
| 43068-0903-08 | 1 BLISTER PACK in 1 DOSE PACK (43068-903-08) / 1 KIT in 1 B... | FANAPT | Vanda Pharmaceuticals Inc. | 2018-09-24 |
| 43068-0904-14 | 14 TABLET in 1 BOTTLE (43068-904-14) | FANAPT | Vanda Pharmaceuticals Inc. | 2024-06-11 |
| 43068-0905-14 | 14 TABLET in 1 BOTTLE (43068-905-14) | FANAPT | Vanda Pharmaceuticals Inc. | 2024-06-11 |
| 43068-0906-08 | 1 BLISTER PACK in 1 DOSE PACK (43068-906-08) / 1 KIT in 1 B... | FANAPT | Vanda Pharmaceuticals Inc. | 2025-05-01 |
| 43068-0907-12 | 1 BLISTER PACK in 1 DOSE PACK (43068-907-12) / 1 KIT in 1 B... | FANAPT | Vanda Pharmaceuticals Inc. | 2025-08-01 |
Observed labelers:
Mylan Pharmaceuticals Inc. (21) ·
Vanda Pharmaceuticals Inc. (17)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.